Company
sperogenix
曙方医药 (Shufang Pharma) is an innovative company focused on the R&D and commercialization of drugs for genetic rare diseases in China. It is committed to providing Chinese rare disease patients with clinically accessible products and offering promising commercial solutions for rare disease therapies.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Yangzhou, Jiangsu, China
- Founded
- 2019
- Legal name
- 曙方医药集团北京罕友医药科技有限公司
Claim, correct or request removal
Record updated 28 September 2026
About
Shufang Pharmaceutical (曙方医药), founded in 2019 and headquartered in Yangzhou High-tech Zone, Jiangsu, is an innovative company focused on the R&D and commercialization of drugs for genetic rare diseases in China. It is committed to providing clinically accessible products for rare disease patients in China and commercial solutions with successful prospects for rare disease treatments.
Products
- Other
- 安迦利伐莫洛龙口服混悬液
Loading relationship preview